Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome. [electronic resource]
Producer: 20090403Description: 169-73 p. digitalISSN:- 1473-5687
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Azathioprine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Interactions
- Drug Therapy, Combination
- Humans
- Immunosuppressive Agents -- administration & dosage
- Inflammatory Bowel Diseases -- drug therapy
- Medical Audit
- Mesalamine -- administration & dosage
- Methyltransferases -- blood
- Recurrence
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.